The Impact of MFN Pricing on the U.S. Biosimila...

By Rene Pretorius

May 23, 2025

Could a cost-cutting policy designed to rein in drug prices backfire on biosimilar competition? The Most Favored Nation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.